Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT06859866

Efficacy of Adjunctive At-Home Photodynamic Therapy (aPDT) in the Treatment of Peri-Implant Mucositis

Led by Koite Health Oy · Updated on 2025-08-05

30

Participants Needed

1

Research Sites

91 weeks

Total Duration

On this page

Sponsors

K

Koite Health Oy

Lead Sponsor

U

University of Roma La Sapienza

Collaborating Sponsor

AI-Summary

What this Trial Is About

The study aims to establish a validated protocol enabling an alternative approach for bacterial biofilm control through the application of a novel at-home photodynamic/antibacterial blue light therapy in addition to non-surgical professional treatment (NST) for peri-implant mucositis. The primary outcomes will include reductions in plaque and bleeding scores, decreases in probing pocket depth, and lower aMMP-8 levels in PISF. Secondary outcomes will include changes in keratinized peri-implant mucosa (KPIM) and patient-reported outcome measures (PROMs).

CONDITIONS

Official Title

Efficacy of Adjunctive At-Home Photodynamic Therapy (aPDT) in the Treatment of Peri-Implant Mucositis

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Presence of at least 20 teeth within the oral cavity
  • Diagnosis of peri-implant mucositis with bleeding or suppuration upon gentle probing, with or without increased probing depth, and no bone loss beyond initial remodeling
  • Willingness and ability to provide written informed consent
Not Eligible

You will not qualify if you...

  • Pregnancy
  • History of periodontitis
  • Use of medications affecting soft tissues in the past 6 months, including antibiotics, anti-inflammatories, anticonvulsants, immunosuppressants, or calcium channel blockers
  • Allergy to the photosensitizer
  • Presence of removable major prostheses or orthodontic appliances
  • Untreated carious lesions

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Department of Oral and Maxillofacial Sciences, Sapienza Università di Roma,

Roma, Italy, 00161

Actively Recruiting

Loading map...

Research Team

M

Mikko Kylmänen, Master of Health Care

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here